Latest news on Laboratorytalk categorised by supplier
Bespak Europe
Address:
Bergen Way
North Lynn Industrial Estate
King's Lynn
PE30 2JJ
UK
Telephone: (UK) +44 1553 691000
http://www.bespak.com
Our RSS feed for news from Bespak Europe
Request to receive our free email newsletter each week
Listing of all 20 news releases from Bespak Europe:
Zogenix signs development agreement with Bespak
User application article Bespak announces completion of a development agreement with Zogenix, a pharmaceutical company focused on the development and commercialisation of medicines to treat the central nervous system (CNS)
News from Bespak Europe ( 6 February 2007)
Selected to develop needle-free solid dose device
Bespak has been appointed by Glide Pharma, formerly known as Caretek Medical, to develop and manufacture its innovative Glide needle-free solid dose injector
News from Bespak Europe (11 October 2006)
Bespak is fully prepared for Exubera Launch
Bespak has commenced full-scale production of the Exubera inhaler
News from Bespak Europe (25 July 2006)
Bespak makes history at plastics industry awards
Bespak, a designer, developer and manufacturer of medical devices, dominated the Plastics Industry Awards 2006, taking home a record-breaking three awards on the night
News from Bespak Europe (16 June 2006)
Successful trial data supports better patient care
Bespak has announced further data to support the unique characteristics of its Easi-fill pressurised metered dose inhaler (pMDI) valve
News from Bespak Europe (25 May 2006)
B+O and Bespak build next generation inhaler
Bang and Olufsen Medicom and Bespak collaborate on next generation inhaler; the Assist Actuated Inhaler features integrated dose counter and easy-to-operate mechanism
News from Bespak Europe (26 April 2006)
Bespak delivers 300 millionth Diskus device
Bespak, a developer and manufacturer of specialty drug delivery and medical devices, has recently commemorated the manufacture of the 300 millionth Diskus device for GlaxoSmithKline
News from Bespak Europe (11 April 2006)
Commercial manager enhances Bespak's US presence
Scott Kellogg will be responsible for creating new business opportunities for manufacturing services division as well as playing a key role in managing the relationship with Nektar Therapeutics
News from Bespak Europe (22 February 2006)
Plant enables end-to-end valve development
Bespak has further enhanced its credentials as a global leader with the commissioning of a specialised and dedicated elastomer manufacturing facility at its King's Lynn site
News from Bespak Europe (31 January 2006)
Bespak welcomes European approval of Exubera
Technical background article Bespak, in conjunction with Nektar Therapeutics, has developed the manufacturing process for Exubera's inhalation device which it will manufacture at its purpose designed facility in Milton Keynes
News from Bespak Europe (31 January 2006)
Bespak wins 2005 F+S award for technology
The award is given in recognition of Bespak's innovations in development of metered dose inhalers (MDIs), complemented by its range of manufacturing services to pharmaceutical and healthcare companies
News from Bespak Europe (31 January 2006)
Expertise features at drug delivery conference
Drug delivery device specialist Bespak presented a research paper and three posters at this year's Drug Delivery to the Lungs conference in London on 9 and 10 December 2004
News from Bespak Europe (14 December 2004)
Studying site-specific delivery of antibodies
Bespak announces a collaborative research programme with the London School of Pharmacy to discover more efficient ways of delivering medication to the respiratory tract
News from Bespak Europe (16 November 2004)
Development programme for dry powder inhaler
Bespak has signed a key new development agreement with Innovata Biomed, the respiratory division of ML Laboratories, which supplies inhaled drug delivery to the pharmaceutical industry
News from Bespak Europe ( 5 July 2004)
It gets right up your nose
Next generation nasal device is capable of delivering an accurate single dose of a wide range of therapeutic agents
News from Bespak Europe (14 October 2003)
Metered dose inhaler valve deal
Chiesi chooses Bespak HFA valve to deliver Budesonide asthma treatment to Europe
News from Bespak Europe (27 February 2003)
Nasal drug delivery research collaboration
Successful nasal delivery of drugs requires efficient targeting of the appropriate deposition sites in the nasal cavity
News from Bespak Europe ( 8 November 2002)
Partnership in nasal drug delivery RandD
Collaboration will form a research and product development partnership for the development and commercialisation of new intellectual property
News from Bespak Europe ( 7 November 2002)
Formulation scientist appointed
Will be involved in testing and developing a range of valve options for pulmonary drug delivery in conjunction with pharmaceutical customers
News from Bespak Europe ( 6 November 2002)
Head of pulmonary product development
Tol Purewal appointed as head of pulmonary product development at developer of innovative drug delivery technologies for the pharmaceutical industry
News from Bespak Europe ( 5 November 2002)
